UnitedHealth Group Incorporated (NYSE:UNH)‘s stock had its “buy” rating reiterated by research analysts at Leerink Swann in a research report issued to clients and investors on Wednesday. They currently have a $240.00 price objective on the healthcare conglomerate’s stock, up from their previous price objective of $225.00. Leerink Swann’s target price points to a potential upside of 18.08% from the stock’s current price. Leerink Swann also issued estimates for UnitedHealth Group’s Q4 2017 earnings at $2.51 EPS, FY2017 earnings at $10.00 EPS, FY2019 earnings at $12.50 EPS and FY2020 earnings at $14.45 EPS.

Other equities research analysts have also issued research reports about the company. Citigroup Inc. increased their price target on UnitedHealth Group from $195.00 to $213.00 and gave the stock a “buy” rating in a research note on Wednesday, July 19th. Cantor Fitzgerald reiterated a “buy” rating and issued a $205.00 price target on shares of UnitedHealth Group in a research note on Friday, July 7th. Stifel Nicolaus reiterated a “buy” rating and issued a $185.00 price target on shares of UnitedHealth Group in a research note on Wednesday, June 28th. BidaskClub lowered UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 19th. Finally, Mizuho set a $235.00 price target on UnitedHealth Group and gave the stock a “buy” rating in a research note on Tuesday, July 18th. Three analysts have rated the stock with a hold rating and twenty-four have issued a buy rating to the stock. The company currently has an average rating of “Buy” and an average target price of $215.27.

UnitedHealth Group (NYSE UNH) traded up 1.28% during midday trading on Wednesday, reaching $205.85. The company had a trading volume of 1,067,878 shares. The company has a market capitalization of $203.59 billion, a price-to-earnings ratio of 23.37 and a beta of 0.63. UnitedHealth Group has a 52 week low of $133.03 and a 52 week high of $207.80. The firm has a 50-day moving average price of $197.17 and a 200-day moving average price of $185.63.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The business had revenue of $50.32 billion during the quarter, compared to analyst estimates of $50.38 billion. During the same quarter in the prior year, the business posted $2.17 EPS. UnitedHealth Group’s revenue for the quarter was up 8.7% compared to the same quarter last year. Analysts expect that UnitedHealth Group will post $9.91 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: “UnitedHealth Group Incorporated (UNH) Stock Rating Reaffirmed by Leerink Swann” was first posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright legislation. The correct version of this news story can be read at https://theolympiareport.com/2017/10/20/unitedhealth-group-incorporated-unh-stock-rating-reaffirmed-by-leerink-swann.html.

In related news, insider Larry C. Renfro sold 50,574 shares of the stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $198.11, for a total value of $10,019,215.14. Following the sale, the insider now directly owns 195,625 shares of the company’s stock, valued at approximately $38,755,268.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Richard T. Burke sold 15,000 shares of the stock in a transaction dated Monday, August 21st. The stock was sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the completion of the sale, the director now directly owns 1,818,898 shares in the company, valued at $348,700,935.58. The disclosure for this sale can be found here. Insiders sold a total of 76,174 shares of company stock worth $14,981,909 over the last three months. 0.89% of the stock is currently owned by corporate insiders.

A number of institutional investors have recently bought and sold shares of UNH. Waldron LP raised its position in UnitedHealth Group by 153.1% in the 1st quarter. Waldron LP now owns 5,765 shares of the healthcare conglomerate’s stock worth $944,000 after purchasing an additional 3,487 shares during the period. WASHINGTON TRUST Co purchased a new stake in UnitedHealth Group in the 1st quarter worth about $235,000. Blue Fin Capital Inc. purchased a new stake in UnitedHealth Group in the 1st quarter worth about $205,000. Webster Bank N. A. raised its position in UnitedHealth Group by 27.0% in the 1st quarter. Webster Bank N. A. now owns 913 shares of the healthcare conglomerate’s stock worth $149,000 after purchasing an additional 194 shares during the period. Finally, Adell Harriman & Carpenter Inc. raised its position in UnitedHealth Group by 36.3% in the 1st quarter. Adell Harriman & Carpenter Inc. now owns 13,096 shares of the healthcare conglomerate’s stock worth $2,148,000 after purchasing an additional 3,485 shares during the period. 86.11% of the stock is currently owned by institutional investors.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.